LONDON (Alliance News) - GlaxoSmithKline PLC will this week announce plans to launch late stage clinical trials on ten new drugs over the next two years, the Daily Telegraph reported Monday, without saying where it got the information. The list will include medicines in Glaxo?s key areas of Read More
LONDON (Alliance News) - Sinclair IS Pharma PLC said Friday that it had acquired dermal filler Atlean from GlaxoSmithKline PLC's dermatology business Stiefel. The company said that Atlean, used to reduce wrinkles, will complement its existing facial care brands Sculptra and Perfectha. Atlea Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that its Phase III study of the combination treatment of Tafinlar and Mekinist for the treatment of metastatic melenoma had reached its primary endpoint. The company said the response rate and interim overall survival results in the s Read More
LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.<br /><br />In a speech at the World Ec Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Royal Mail</strong> PLC reported a 2% increase in like-for-like revenues for the first half of the year, driven by further growth in its Read More
LONDON (Alliance News) - Pharmaceuticals giant GlaxoSmithKline PLC said Friday that it had received a recommendation for marketing authorisation for its Eperzan treatment for type 2 diabetes from the European Medicines Agency's Committee for Medical Products for Human Use. The recommendatio Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />KEPLER CHEUVREUX STARTS BP WITH 'BUY' - PRICE TARGET 545 PENCE <br />----------<br />KEPLER CHEUVREUX STARTS BG GROUP WITH 'HOLD Read More
LONDON (Alliance News) - UK shares have opened higher Friday, as Bank of England Governor Mark Carney backed off of forward guidance and said there is "no immediate need" to raise interest rates.<br /><br /><strong>Royal Mail</strong> has reported a 2% increase in like-for-like revenues for th Read More
(An item published at 1259 GMT misstated the market prices. The correct version follows.) LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and who Read More
LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that its joint venture Viiv Healthcare Ltd saw its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission. This regulation authori Read More
LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said that Executive Director Moncef Slaoui was allocated 15 American Depositary Shares at a price of USD54.10 each on January 17. Glaxo shares closed at 1,657.68 pence per share Monday, up 0.8%. B Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE RAISES NEXT PRICE TARGET TO 6500 (5500) PENCE - 'NEUTRAL' <br />----------<br />BERENBERG RAI Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Friday said Deidre Connelly, divisional president and Bill Louv, divisional senior vice president bought American Depositary shares following the re-investment of dividends January 9.<br /><br />Details are as follows. <table class=" Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said Patrick Valance, a divisional president, acquired 148 shares at a price of 1,607.6318 pence per share on Friday last week. Shares in the healthcare group were up 11.91p at 1,630.91p Thursday afternoon. By Arvind Bhunjun; arvi Read More